This condition, now “trending” among patients undergoing transcatheter aortic valve replacement (TAVR), has expanded to almost all patients we treat, always with the same outcome: the prognosis is bad, so bad that it might warrant making the difficult decision of not going forward. The association between frailty and bad prognosis is easy to see and<a href="https://solaci.org/en/2018/09/11/frailty-what-happens-when-we-are-too-late-in-critical-lower-limb-ischemia/" title="Read more" >...</a>
The obvious risk of bleeding posed by aspirin was too clear in this work, casting a shadow of doubt over the indication of aspirin for primary prevention in diabetic patients. According to the ASCEND trial, presented at the European Society of Cardiology (ESC) 2018 Congress and simultaneously published in NEJM, aspirin reduces cardiovascular events as<a href="https://solaci.org/en/2018/08/28/esc-2018-ascend-aspirin-for-primary-prevention-in-diabetic-patients-fails-the-cost-benefit-analysis/" title="Read more" >...</a>
As observed at the preliminary analysis that motivated the FUTURE trial early termination, the use of fractional flow reserve (FFR) to guide revascularization in an unselected population with multivessel disease was associated to twice the mortality rate in one year, with no beneficial impact on other end points. Even though the combined end point of<a href="https://solaci.org/en/2018/08/28/esc-2018-future-a-thorn-in-ffr-and-more-questions-than-answers/" title="Read more" >...</a>
JAMA Cardiology dedicated a special with 4 articles on different issues women continue to face when considering this area of expertise, or when they have already chosen this fascinating field but still feel undervalued or discriminated compared with their male colleagues. One of the studies showed the career preferences of med school students. What trainees<a href="https://solaci.org/en/2018/08/14/women-in-cardiology-still-underrepresented-in-a-field-full-of-men/" title="Read more" >...</a>
The European guidelines on hypertension have been updated and now feature differences compared with American guidelines regarding how to diagnose and treat patients with high blood pressure. The main difference particularly lies in how aggressive physicians should be in lowering blood pressure. These data are available from a preview of the document presented at the<a href="https://solaci.org/en/2018/07/27/new-european-hypertension-guidelines-contrast-with-american-recommendations/" title="Read more" >...</a>
Once again, the most relevant scientific societies in the world have trusted SOLACI Congress to debate different topics on interventional cardiology, and so we have put together different joint sessions tailored to your interests, to be presented by the most prestigious faculty members in the world. Next, see what joint sessions you will be able<a href="https://solaci.org/en/2018/07/26/descubra-las-sesiones-conjuntas-del-congreso-solaci-socime-2018-2/" title="Read more" >...</a>
As regards the use of antithrombotic agents, the risk of bleeding will always be an issue, and in the case of aspirin this risk is twice as big: it does have the desired antiaggregation effect, but on top of the increased bleeding risk, it has a damaging effect on stomach lining that increases the risk<a href="https://solaci.org/en/2018/07/25/can-we-prevent-cardiovascular-events-without-aspirin/" title="Read more" >...</a>
The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is very frequent and many of these medications are sold over-the-counter, but they can expose patients with atrial fibrillation using warfarin or dabigatran to potentially dangerous bleeding. Such a combination is a “perfect storm” of sorts, since atrial fibrillation is the most frequent type of arrhythmia and its<a href="https://solaci.org/en/2018/07/24/nsaids-and-risk-of-bleeding-in-patients-with-atrial-fibrillation/" title="Read more" >...</a>
This syndrome, which can be reverted, is also one of the causes of preventable stroke, at least in the context of carotid endarterectomy. At present, there is little information on the incidence of this condition in the context of carotid stenting, which is the purpose of this study, in addition to providing tips to prevent it.<a href="https://solaci.org/en/2018/07/23/post-carotid-stenting-cerebral-hyperperfusion-a-preventable-complication/" title="Read more" >...</a>
During valve replacement, cerebral protection systems may capture debris in up to 99% of all patients. In over half of them, these particles are >1 mm. The particles captured during procedures in which Evolut R or Lotus valves were used were more and larger compared with those captured with the Sapien balloon-expandable valve. Beyond differences among valves,<a href="https://solaci.org/en/2018/07/06/differences-in-debris-captured-according-to-valve-type/" title="Read more" >...</a>